|
11.
|
|
|
12.
|
|
12 p, 1.9 MB |
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
/
Vigón, Lorena (Instituto de Salud Carlos III) ;
Vázquez-Morón, Sonia (Instituto de Salud Carlos III) ;
Berenguer, Juan (Hospital General Universitario Gregorio Marañón) ;
González-García, Juan (Hospital Universitario La Paz (Madrid)) ;
Jiménez-Sousa, Ma Ángeles (Instituto de Salud Carlos III) ;
Guardiola Tey, Jose Maria (Institut d'Investigació Biomèdia Sant Pau) ;
Crespo Casal, Manuel (Hospital Álvaro Cunqueiro (Vigo)) ;
de los Santos, Ignacio (Hospital Universitario de la Princesa (Madrid)) ;
Von Wichmann, Miguel A. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Carrero, Ana (Hospital General Universitario Gregorio Marañón) ;
Yélamos, María Belén (Universidad Complutense de Madrid) ;
Gómez, Julián (Universidad Complutense de Madrid) ;
Resino, Salvador (Instituto de Salud Carlos III) ;
Martínez, Isidoro (Instituto de Salud Carlos III) ;
Miralles, P. (Hospital General Universitario Gregorio Marañón) ;
López, J.C. (Hospital General Universitario Gregorio Marañón) ;
Parras, F. (Hospital General Universitario Gregorio Marañón) ;
Padilla, B. (Hospital General Universitario Gregorio Marañón) ;
Aldamiz-Echevarría, T. (Hospital General Universitario Gregorio Marañón) ;
Tejerina, F. (Hospital General Universitario Gregorio Marañón) ;
Díez, C. (Hospital General Universitario Gregorio Marañón) ;
Pérez-Latorre, L. (Hospital General Universitario Gregorio Marañón) ;
Fanciulli, C. (Hospital General Universitario Gregorio Marañón) ;
Gutiérrez, I. (Hospital General Universitario Gregorio Marañón) ;
Ramírez, M. (Hospital General Universitario Gregorio Marañón) ;
Carretero, S. (Hospital General Universitario Gregorio Marañón) ;
Bellón, J.M. (Hospital General Universitario Gregorio Marañón) ;
Bermejo, Javier (Hospital General Universitario Gregorio Marañón) ;
Hontañón, V. (Hospital Universitario La Paz (Madrid)) ;
Arribas, Jose (Hospital Universitario La Paz (Madrid)) ;
Montes, M.L. (Hospital Universitario La Paz (Madrid)) ;
Bernardino, I. (Hospital Universitario La Paz (Madrid)) ;
Pascual, J.F. (Hospital Universitario La Paz (Madrid)) ;
Zamora, F. (Hospital Universitario La Paz (Madrid)) ;
Peña, J.M. (Hospital Universitario La Paz (Madrid)) ;
Arnalich, F. (Hospital Universitario La Paz (Madrid)) ;
Díaz, M. (Hospital Universitario La Paz (Madrid)) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Sanz, J. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Bustinduy, M.J. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Iribarren, J.A. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Rodríguez-Arrondo, F. (Hospital de Donostia (Sant Sebastià, País Basc)) ;
Eynde, E.Van den (Hospital Universitari Vall d'Hebron) ;
Pérez, M. (Hospital Universitari Vall d'Hebron) ;
Ribera, E. (Hospital Universitari Vall d'Hebron) ;
Casado, José Luis (Hospital Universitario Ramón y Cajal (Madrid)) ;
Dronda, F. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Moreno, A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Pérez-Elías, M.J. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Sanfrutos, M.A. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Moreno, S. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Quereda, C. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Arranz, A. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Casas, E. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Miguel, J.de (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Schroeder, S. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Vergas, J. (Hospital Clínico San Carlos (Madrid)) ;
Téllez, M.J. (Hospital Clínico San Carlos (Madrid)) ;
Vinuesa, D. (Hospital Universitario San Cecilio (Granada)) ;
Muñoz, L. (Hospital Universitario San Cecilio (Granada)) ;
Hernández-Quero, J. (Hospital Universitario San Cecilio (Granada)) ;
Ferrer, A. (Hospital Clínico Universitario) ;
Galindo, M.J. (Hospital Clínico Universitario) ;
Ortiz, L. (Hospital General Universitario) ;
Ortega, E. (Hospital General Universitario) ;
Montero, M. (Hospital Universitari La Fe) ;
Blanes, M. (Hospital Universitari La Fe) ;
Cuellar, S. (Hospital Universitari La Fe) ;
Lacruz, J. (Hospital Universitari La Fe) ;
Salavert, M. (Hospital Universitari La Fe) ;
López-Aldeguer, J. (Hospital Universitari La Fe) ;
Pérez, G. (Hospital Universitario de Getafe (Madrid)) ;
Gaspar, G. (Hospital Universitario de Getafe (Madrid)) ;
Yllescas, M. (Fundación SEIMC-GESIDA) ;
Crespo, P. (Fundación SEIMC-GESIDA) ;
Aznar, E. (Fundación SEIMC-GESIDA) ;
Esteban, H. (Fundación SEIMC-GESIDA) ;
Universitat Autònoma de Barcelona
The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2 envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-IFNα + ribavirin anti-HCV therapy. [...]
2019 -  10.1038/s41598-019-48592-5
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 12163
|
|
|
13.
|
|
7 p, 875.8 KB |
Epidemiological and clinical characteristics of children hospitalized due to influenza A and B in the south of Europe, 2010-2016
/
Jané, Mireia (Instituto de Salud Carlos III) ;
Vidal, Maria José (Agència de Salut Pública de Catalunya) ;
Soldevila, Núria (Universitat de Barcelona) ;
Romero, Arancha (Universitat de Barcelona) ;
Martínez, Ana (Instituto de Salud Carlos III) ;
Torner, Nuria (Instituto de Salud Carlos III) ;
Godoy, Pere (Instituto de Salud Carlos III) ;
Launes, Cristian (Sant Joan de Deu Children's Hospital) ;
Rius i Gibert, Maria Cristina (Agència de Salut Pública de Barcelona) ;
Marcos, Maria Angeles (Hospital Clínic i Provincial de Barcelona) ;
Domínguez, Ángela (Universitat de Barcelona) ;
Universitat Autònoma de Barcelona
Influenza produces annual epidemics that affect 5-15% of the world population. Complications and hospitalizations are more frequent in childhood. This study describes and analyses the epidemiological and clinical characteristics of children hospitalized due to confirmed influenza in influenza surveillance sentinel hospitals in Catalonia. [...]
2019 - 10.1038/s41598-019-49273-z
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 12853
|
|
|
14.
|
|
12 p, 484.6 KB |
Safety profile of the adjuvanted recombinant zoster vaccine : Pooled analysis of two large randomised phase 3 trials
/
López Fauqued, Marta (GlaxoSmithKline (GSK)) ;
Campora, Laura (GlaxoSmithKline (GSK)) ;
Delannois, Frédérique (GlaxoSmithKline (GSK)) ;
El Idrissi, Mohamed (GlaxoSmithKline (GSK)) ;
Oostvogels, Lidia (GlaxoSmithKline (GSK)) ;
De Looze, Ferdinandus (University of Queensland) ;
Diez-Domingo, Javier (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat (València)) ;
Heineman, Thomas (GlaxoSmithKline (GSK)) ;
Lal, Himal (GlaxoSmithKline (GSK)) ;
McElhaney, Janet (Health Sciences North Research Institute) ;
McNeil, Shelly (Dalhousie University) ;
Yeo, Wilfred (University of Wollongong) ;
Tavares-Da-Silva, Fernanda (GlaxoSmithKline (GSK)) ;
Ahonen, Anitta (University of Tampere) ;
Avelino-Silva, Thiago (University of São Paulo Medical School) ;
Barba-Gomez, José Fernando (Instituto Dermatológico de Jalisco) ;
Berglund, Johan (Blekinge Institute of Technology) ;
Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ;
Caso, Covadonga (Hospital Clínico San Carlos (Madrid)) ;
Chlibek, Roman (University of Defence) ;
Choi, Won Suk (Korea University College of Medicine) ;
Cunningham, Anthony (University of Sydney) ;
Desole, Maria Giuseppina (Servizio di Igiene Pubblica) ;
Eizenberg, Peter (Doctors of Ivanhoe) ;
Esen, Meral (University Clinic of Tübingen) ;
Espié, Emmanuelle (GlaxoSmithKline (GSK)) ;
Gervais, Pierre (Q&T Research Sherbrooke) ;
Ghesquiere, Wayne (University of British Columbia) ;
Godeaux, Olivier O. (GlaxoSmithKline (GSK)) ;
Gorfinkel, Iris (York University) ;
Hui, David Shu Cheong (Prince of Wales Hospital (Australia)) ;
Hwang, Shinnjang (Taipei Veterans General Hospital and National Yang Ming University School of Medicine) ;
Korhonen, Tiina (University of Tampere Medical School) ;
Kovac, Martina (GlaxoSmithKline (GSK)) ;
Ledent, Edouard Y. (GlaxoSmithKline (GSK)) ;
Leung, Edward Man Fuk (Hong Kong Association of Gerontology) ;
Levin, Myron (University of Colorado Anschutz Medical Campus) ;
Perez, Silvia Narejos (CAP Centelles) ;
de Andrade Neto, José Luiz (Instituto A. Z. de Pesquisa e Ensino) ;
Pauksens, Karlis (Uppsala University Hospital) ;
Poder, Airi (Kliiniliste Uuringute Keskus) ;
Rodriguez de la Pinta, Maria Luisa (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Rombo, Lars (Uppsala University) ;
Schwarz, Tino Francis (Standort Juliusspital) ;
Smetana, Jan (University of Defence) ;
Staniscia, Tommaso (University G. d'Annunzio of Chieti-Pescara) ;
Tinoco-Fávila, Juan Carlos (Hospital General de Durango) ;
Toma, Azhar (Manna Research) ;
Vastiau, Ilse (GlaxoSmithKline (GSK)) ;
Vesikari, Timo H. (University of Tampere) ;
Volpi, Antonio (A.O. Univesitaria Policlinico Tor Vergata) ;
Watanabe, Daisuke (Kobe University Graduate School of Medicine) ;
Weckx, Lily (Federal University of Sao Paulo) ;
Zahaf, Toufik (GlaxoSmithKline (GSK)) ;
Universitat Autònoma de Barcelona
The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies. [...]
2019 - 10.1016/j.vaccine.2019.03.043
Vaccine, Vol. 37 Núm. 18 (24 2019) , p. 2482-2493
|
|
|
15.
|
|
3 p, 399.8 KB |
Vector competence of aedes caspius and ae. Albopictus mosquitoes for zika virus, Spain
/
Gutiérrez-López, Rafael (Estación Biológica de Doñana) ;
Bialosuknia, Sean M. (New York State Department of Health) ;
Ciota, Alexander T. (New York State Department of Health) ;
Montalvo Porro, Tomas (Institut d'Investigació Biomèdica Sant Pau) ;
Martínez-De la Puente, Josue (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Gangoso, Laura (Estación Biológica de Doñana) ;
Figuerola, Jordi (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Kramer, Laura D. (New York State Department of Health) ;
Universitat Autònoma de Barcelona
We assessed the vector competence of Aedes caspius and Aedes albopictus mosquitoes in Spain for the transmission of Zika virus. Whereas Ae. albopictus mosquitoes were a competent vector, Ae. caspius mosquitoes were unable to transmit Zika virus. [...]
2019 - 10.3201/eid2502.171123
Emerging Infectious Diseases, Vol. 25 Núm. 2 (january 2019) , p. 346-348
|
|
|
16.
|
|
11 p, 1.4 MB |
Mumps : MMR vaccination and genetic diversity of mumps virus, 2007-2011 in Catalonia, Spain
/
Barrabeig, Irene (Hospital Universitari de Bellvitge) ;
Antón, Andrés (Hospital Clínic i Provincial de Barcelona) ;
Torner, Nuria (Hospital Clínic i Provincial de Barcelona) ;
Pumarola Suñé, Tomàs (Hospital Clínic i Provincial de Barcelona) ;
Costa, Josep (Hospital Clínic i Provincial de Barcelona) ;
Domínguez, Àngela (Universitat de Barcelona) ;
Rius i Gibert, Maria Cristina (Agència de Salut Pública de Barcelona) ;
Universitat Autònoma de Barcelona
Mumps is a vaccine-preventable disease but outbreaks have been reported in persons vaccinated with two doses of MMR vaccine. The objective was to describe the demographic features, vaccination effectiveness and genetic mumps virus diversity among laboratory-confirmed cases between 2007 and 2011 in Catalonia. [...]
2019 - 10.1186/s12879-019-4496-z
BMC Infectious diseases, Vol. 19 Núm. 1 (september 2019) , p. 954
|
|
|
17.
|
|
16 p, 2.4 MB |
Gag Virus-like Particles Functionalized with SARS-CoV-2 Variants: Generation, Characterization and Recognition by COVID-19 Convalescent Patients' Sera
/
Boix-Besora, Arnau (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Gòdia, Francesc (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental) ;
Cervera Gracia, Laura (Universitat Autònoma de Barcelona. Departament d'Enginyeria Química, Biològica i Ambiental)
The robustness, safety, versatility, and high immunogenicity of virus-like particles (VLPs) make them a promising approach for the generation of vaccines against a broad range of pathogens. VLPs are recombinant macromolecular structures that closely mimic the native conformation of viruses without carrying viral genetic material. [...]
2023 - 10.3390/vaccines11111641
Vaccines (Basel), Vol. 11, Issue 11 (October 2023) , art. 1641
|
|
|
18.
|
|
16 p, 7.0 MB |
Genetic diversification patterns in swine influenza A virus (H1N2) in vaccinated and nonvaccinated animals
/
López-Valiñas, Álvaro (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ;
Valle González, Marta (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ;
Pérez, Marta (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ;
Darji, Ayub (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ;
Chiapponi, Chiara (Istituto Zooprofilattico Sperimentale della Lombardia ed Emilia-Romagna. WOAH Reference Laboratory for Swine Influenza) ;
Ganges, Llilianne (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal) ;
Segalés, Joaquim. (Universitat Autònoma de Barcelona. Departament de Sanitat i d'Anatomia Animals) ;
Núñez, J. Ignacio (Unitat mixta d'investigació IRTA-UAB en Sanitat Animal. Centre de Recerca en Sanitat Animal)
Influenza A viruses (IAVs) are characterized by having a segmented genome, low proofreading polymerases, and a wide host range. Consequently, IAVs are constantly evolving in nature causing a threat to animal and human health. [...]
2023 - 10.3389/fcimb.2023.1258321
Frontiers in cellular and infection microbiology, Vol. 13 (september 2023)
|
|
|
19.
|
|
11 p, 1018.7 KB |
Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe
/
Mena, Marisa (Hospital Universitari de Bellvitge) ;
Frias-Gomez, Jon (Hospital Universitari de Bellvitge) ;
Taberna, Miren (Hospital Universitari de Bellvitge) ;
Quirós, Beatriz (Hospital Universitari de Bellvitge) ;
Marquez, Sandra (Hospital Universitari de Bellvitge) ;
Clavero, Omar (de Hospital Universitari de Bellvitge) ;
Baena, Antoni. (Hospital Universitari de Bellvitge) ;
Lloveras, Belén (Hospital del Mar (Barcelona, Catalunya)) ;
Alejo, María (Hospital General de l'Hospitalet) ;
León i Vintró, Xavier (Institut d'Investigació Biomèdica Sant Pau) ;
García, Jacinto Montero (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ;
Mesía, Ricard (Institute Catala Oncologia) ;
Bermejo, Josep Oriol (Hospital Universitari de Bellvitge) ;
Bonfill Abella, Teresa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Aguilà, Antón (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Guix, Marta (Hospital del Mar (Barcelona, Catalunya)) ;
Hijano, Rafael (Hospital del Mar (Barcelona, Catalunya)) ;
Pavón, Miguel Ángel (Hospital Universitari de Bellvitge) ;
Torres, Montserrat A. (Hospital Universitari de Bellvitge) ;
Tous, Sara (Hospital Universitari de Bellvitge) ;
Clèries, Ramón (Hospital Universitari de Bellvitge) ;
Alemany, Laia (Hospital Universitari de Bellvitge) ;
Universitat Autònoma de Barcelona
The incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing in some regions. Nevertheless, the epidemiology of this disease has not been extensively investigated in southern Europe. [...]
2020 - 10.1038/s41598-020-70118-7
Scientific reports, Vol. 10 Núm. 1 (january 2020) , p. 13219
|
|
|
20.
|
|
9 p, 565.0 KB |
The role of Epstein-Barr virus in adults with bronchiectasis : A prospective cohort study
/
Chen, C.L. (Guangdong General Hospital (Guangdong Academy of Medical Sciences)) ;
Huang, Y. (First Affiliated Hospital of Guangzhou Medical University) ;
Martinez-Garcia, M.A. (Hospital Universitari i Politècnic La Fe (València)) ;
Yuan, J.J. (First Affiliated Hospital of Guangzhou Medical University) ;
Li, H.M. (First Affiliated Hospital of Guangzhou Medical University) ;
de la Rosa Carrillo, David (Institut d'Investigació Biomèdica Sant Pau) ;
Han, X.R. (First Affiliated Hospital of Guangzhou Medical University) ;
Chen, R.C. (Shenzhen People's Hospital) ;
Guan, W.J. (First Affiliated Hospital of Guangzhou Medical University) ;
Zhong, N.S. (First Affiliated Hospital of Guangzhou Medical University) ;
Universitat Autònoma de Barcelona
Epstein-Barr virus (EBV) is implicated in the progression of chronic obstructive pulmonary disease. We aimed to determine whether EBV correlates with bronchiectasis severity, exacerbations, and progression. [...]
2020 - 10.1093/ofid/ofaa235
Open Forum Infectious Diseases, Vol. 7 Núm. 8 (january 2020) , p. ofaa235
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
